|
⚲
|
| Keyboard |
| Beigelman Leonid
✚
|
|
|---|---|
| CIK # | 0001824721 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001824721] | |
| 4 | [0001824721] | |
| SC 13G | [0001824721] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Beigelman Leonid | Aligos Therapeutics Inc | [2021-02-11] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Beigelman Leonid | |
| Aligos Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2023-03-15 | Grant | 169,500 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-07-07 | Grant | 113,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-02-04 | Grant | 56,700 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-02-04 | Grant | 226,800 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2020-12-01 | Grant | 300,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 3,359 | ||
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 1,437 | ||
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 21,724 | ||
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 1,437 | ||
|
Aligos Therapeutics Inc ALGS
Series B-2 Preferred Stock · derivative
|
2020-10-20 | Conversion | 1,437 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 163,842 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 163,842 | ||
|
Aligos Therapeutics Inc ALGS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 13,559 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-1 Preferred Stock · derivative
|
2020-10-20 | Conversion | 50,781 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-1 Preferred Stock · derivative
|
2020-10-20 | Conversion | 3,359 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-1 Preferred Stock · derivative
|
2020-10-20 | Conversion | 3,359 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-2 Preferred Stock · derivative
|
2020-10-20 | Conversion | 21,724 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-2 Preferred Stock · derivative
|
2020-10-20 | Conversion | 1,437 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 13,559 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 13,559 | ||
| showing 20 of 23 most recent transactions | |||||